124 related articles for article (PubMed ID: 11260078)
1. Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patients.
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Diehl V; Zankovich R; Niederle N; Leder LD; Schaefer HE
Br J Haematol; 2001 Mar; 112(3):727-39. PubMed ID: 11260078
[TBL] [Abstract][Full Text] [Related]
2. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Leder LD; Schaefer HE
Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Diehl V; Zankovich R; Niederle N; Leder LD; Schaefer HE
J Clin Oncol; 2001 Jun; 19(12):2994-3009. PubMed ID: 11408494
[TBL] [Abstract][Full Text] [Related]
4. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
[TBL] [Abstract][Full Text] [Related]
5. Impact of bone marrow morphology on multivariate risk classification in chronic myelogenous leukemia.
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Diehl V; Niederle N; Schaefer HE
Acta Haematol; 2003; 109(1):53-6. PubMed ID: 12486326
[No Abstract] [Full Text] [Related]
6. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Spohr M; Diehl V; Zankovich R; Niederle N; Leder LD
Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Goekce D; Diehl V; Zankovich R; Schaefer HE
J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
[TBL] [Abstract][Full Text] [Related]
9. Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow.
Thiele J; Kvasnicka HM; Titius BR; Parpert U; Nebel R; Zankovich R; Dienemann D; Stein H; Diehl V; Fischer R
Ann Hematol; 1993 Jun; 66(6):291-302. PubMed ID: 8318559
[TBL] [Abstract][Full Text] [Related]
10. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Schaefer HE
Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zirbes TK; Birnbaum F; Kressmann C; Melguizo-Grahmann M; Frackenpohl H; Sprungmann C; Leder LD; Diehl V; Zankovich R; Schaefer HE; Niederle N; Fischer R
Leuk Lymphoma; 2000 Jan; 36(3-4):295-308. PubMed ID: 10674901
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukemia.
Thiele J; Kvasnicka HM
Leuk Lymphoma; 2001; 42(5):855-62. PubMed ID: 11697640
[TBL] [Abstract][Full Text] [Related]
13. Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study.
Thiele J; Kvasnicka HM; Niederle N; Kloke O; Schmidt M; Lienhard H; Zirbes T; Meuter RB; Leder LD; Fischer R
Am J Hematol; 1995 Sep; 50(1):30-9. PubMed ID: 7545352
[TBL] [Abstract][Full Text] [Related]
14. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Niederle N; Zirbes TK; Schmidt M; Dammasch J; Meuter BR; Leder LD; Kloke O; Diehl V
Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
[TBL] [Abstract][Full Text] [Related]
15. The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1.
Hehlmann R; Heimpel H; Kolb HJ; Heinze B; Hochhaus A; Griesshammer M; Pralle H; Queisser WP; Essers U; Falge C
Leuk Lymphoma; 1993; 11 Suppl 1():159-68. PubMed ID: 8251890
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study Group.
Hehlmann R; Ansari H; Hasford J; Heimpel H; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Reiter A; Hochhaus A
Br J Haematol; 1997 Apr; 97(1):76-85. PubMed ID: 9136944
[TBL] [Abstract][Full Text] [Related]
17. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation.
Thiele J; Kvasnicka HM; Beelen DW; Pilgram B; Rose A; Leder LD; Schaefer UW
Leukemia; 2000 Aug; 14(8):1378-85. PubMed ID: 10942232
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors and survival in chronic myeloproliferative disorders].
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Schaefer HE
Pathologe; 2000 Jan; 21(1):63-72. PubMed ID: 10663670
[TBL] [Abstract][Full Text] [Related]
20. Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group.
Hehlmann R; Ansari H; Hasford J; Heimpel H
Semin Hematol; 1993 Jul; 30(3 Suppl 3):44-8. PubMed ID: 8235707
[No Abstract] [Full Text] [Related]
[Next] [New Search]
